 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, September 17, 2003, 23(24):8596-8607
Previous Article | Next Article
A Peptide Inhibitor of c-Jun N-Terminal Kinase Protects against Both Aminoglycoside and Acoustic Trauma-Induced Auditory Hair Cell Death and Hearing Loss
J. Wang,1 T. R. Van De Water,2 C. Bonny,3 F. de Ribaupierre,4 J. L. Puel,1 andA. Zine1,4 1Institut National de la Santé et de la Recherche Médicale U583, Physiopathologie et Thérapie des Déficits Sensoriels et Moteurs, Université de Montpellier I, 34090 Montpellier, France, 2Cochlear Implant Research Program, University of Miami Ear Institute, Miami, Florida 33136, 3Division de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, 1011 Lausanne, Switzerland, and 4 Institut de Physiologie, Université de Lausanne, 1005 Lausanne, Switzerland
Hearing loss can be caused by a variety of insults, including acoustic trauma and exposure to ototoxins, that principally effect the viability of sensory hair cells via the MAP kinase (MAPK) cell death signaling pathway that incorporates c-Jun N-terminal kinase (JNK).
We evaluated the otoprotective efficacy of D-JNKI-1, a cell permeable peptide that blocks the MAPK–JNK signal pathway. The experimental studies included organ cultures of neonatal mouse cochlea exposed to an ototoxic drug and cochleae of adult guinea pigs that were exposed to either an ototoxic drug or acoustic trauma. Results obtained from the organ of Corti explants demonstrated that the MAPK–JNK signal pathway is associated with injury and that blocking of this signal pathway prevented apoptosis in areas of aminoglycoside damage. Treatment of the neomycin-exposed organ of Corti explants with D-JNKI-1 completely prevented hair cell death initiated by this ototoxin. Results from in vivo studies showed that direct application of D-JNKI-1 into the scala tympani of the guinea pig cochlea prevented nearly all hair cell death and permanent hearing loss induced by neomycin ototoxicity. Local delivery of D-JNKI-1 also prevented acoustic trauma-induced permanent hearing loss in a dose-dependent manner. These results indicate that the MAPK–JNK signal pathway is involved in both ototoxicity and acoustic trauma-induced hair cell loss and permanent hearing loss. Blocking this signal pathway with D-JNKI-1 is of potential therapeutic value for long-term protection of both the morphological integrity and physiological function of the organ of Corti during times of oxidative stress.
Key words: neomycin; ototoxicity; acoustic trauma; noise-induced hearing loss; apoptosis of hair cells; c-Jun N-terminal kinase (JNK); JNK inhibition; organ of Corti
Received April 17, 2003; revised July 7, 2003; accepted July 15, 2003.
This article has been cited by other articles:
M. Lahne and J. E. Gale
Damage-Induced Activation of ERK1/2 in Cochlear Supporting Cells Is a Hair Cell Death-Promoting Signal That Depends on Extracellular ATP and Calcium
J. Neurosci., May 7, 2008; 28(19): 4918 - 4928.
[Abstract] [Full Text] [PDF]
G. Milano, S. Morel, C. Bonny, M. Samaja, L. K. von Segesser, P. Nicod, and G. Vassalli
A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1828 - H1835.
[Abstract] [Full Text] [PDF]
J. Wang, J. Ruel, S. Ladrech, C. Bonny, T. R. van de Water, and J.-L. Puel
Inhibition of the c-Jun N-Terminal Kinase-Mediated Mitochondrial Cell Death Pathway Restores Auditory Function in Sound-Exposed Animals
Mol. Pharmacol., March 1, 2007; 71(3): 654 - 666.
[Abstract] [Full Text] [PDF]
J. Tan and R. K. Shepherd
Aminoglycoside-Induced Degeneration of Adult Spiral Ganglion Neurons Involves Differential Modulation of Tyrosine Kinase B and p75 Neurotrophin Receptor Signaling
Am. J. Pathol., August 1, 2006; 169(2): 528 - 543.
[Abstract] [Full Text] [PDF]
Z.-Y. Zhuang, Y.-R. Wen, D.-R. Zhang, T. Borsello, C. Bonny, G. R. Strichartz, I. Decosterd, and R.-R. Ji
A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance.
J. Neurosci., March 29, 2006; 26(13): 3551 - 3560.
[Abstract] [Full Text] [PDF]
G. M. Kalinec, M. E. Fernandez-Zapico, R. Urrutia, N. Esteban-Cruciani, S. Chen, and F. Kalinec
Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss
PNAS, November 1, 2005; 102(44): 16019 - 16024.
[Abstract] [Full Text] [PDF]
N. Iijima, Y. Yanagawa, J. M. Clingan, and K. Onoe
CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells
Int. Immunol., September 1, 2005; 17(9): 1201 - 1212.
[Abstract] [Full Text] [PDF]
S. Abdelli, J. Ansite, R. Roduit, T. Borsello, I. Matsumoto, T. Sawada, N. Allaman-Pillet, H. Henry, J. S. Beckmann, B. J. Hering, et al.
Intracellular Stress Signaling Pathways Activated During Human Islet Preparation and Following Acute Cytokine Exposure
Diabetes, November 1, 2004; 53(11): 2815 - 2823.
[Abstract] [Full Text] [PDF]
R. K. Barr, R. M. Hopkins, P. M. Watt, and M. A. Bogoyevitch
Reverse Two-hybrid Screening Identifies Residues of JNK Required for Interaction with the Kinase Interaction Motif of JNK-interacting Protein-1
J. Biol. Chem., October 8, 2004; 279(41): 43178 - 43189.
[Abstract] [Full Text] [PDF]
R. K. Barr, I. Boehm, P. V. Attwood, P. M. Watt, and M. A. Bogoyevitch
The Critical Features and the Mechanism of Inhibition of a Kinase Interaction Motif-based Peptide Inhibitor of JNK
J. Biol. Chem., August 27, 2004; 279(35): 36327 - 36338.
[Abstract] [Full Text] [PDF]
S. J. Vannucci and H. Hagberg
Hypoxia-ischemia in the immature brain
J. Exp. Biol., August 15, 2004; 207(18): 3149 - 3154.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|